Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Analgesia With Lidocaine or Extended-Release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
This study is currently recruiting participants.
Study NCT00414453 Information provided by University of Rochester
First Received: December 19, 2006 Last Updated: February 12, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neuropathic Pain
Chronic Pain
Multiple Sclerosis
Additional conditions recognized in this trial
Neuralgia
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pain
Pathologic Processes
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
Lidocaine patch 5%
Extended-release oxycodone
Placebo lidocaine patches
Additional drug interventions recognized in this trial
Lidocaine
Oxycodone
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Anesthetics
Anesthetics, Local
Anti-Arrhythmia Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Rochester
Endo Pharmaceuticals
Back to top of Main Content
